SLI
2.011,28
PKT
-3,07
PKT
-0,15
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09:26 | Novartis Equal Weight | Barclays Capital | |
| 09:21 | Nestlé Equal Weight | Barclays Capital | |
| 08:31 | Givaudan Equal Weight | Barclays Capital | |
| 26.03.26 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 26.03.26 | Givaudan Neutral | UBS AG | |
| 26.03.26 | Zurich Insurance Hold | Deutsche Bank AG | |
| 26.03.26 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 25.03.26 | Swiss Re Neutral | UBS AG | |
| 25.03.26 | Nestlé Neutral | UBS AG | |
| 25.03.26 | Richemont Overweight | Barclays Capital | |
| 25.03.26 | Nestlé Hold | Deutsche Bank AG | |
| 24.03.26 | Nestlé Hold | Jefferies & Company Inc. | |
| 24.03.26 | Novartis Buy | Deutsche Bank AG | |
| 24.03.26 | Givaudan Hold | Deutsche Bank AG | |
| 23.03.26 | Richemont Sector Perform | RBC Capital Markets | |
| 23.03.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 23.03.26 | Novartis Neutral | UBS AG | |
| 23.03.26 | Richemont Overweight | JP Morgan Chase & Co. | |
| 23.03.26 | Swiss Re Underweight | Barclays Capital | |
| 20.03.26 | Novartis Equal Weight | Barclays Capital | |
| 20.03.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 19.03.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 19.03.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 18.03.26 | Nestlé Sector Perform | RBC Capital Markets | |
| 18.03.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 18.03.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 17.03.26 | UBS Underweight | Barclays Capital | |
| 17.03.26 | Givaudan Overweight | Barclays Capital | |
| 17.03.26 | Givaudan Neutral | UBS AG | |
| 12.03.26 | Roche Hold | Deutsche Bank AG | |
| 12.03.26 | Roche Overweight | Barclays Capital | |
| 12.03.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 11.03.26 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.03.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 10.03.26 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 10.03.26 | Roche Hold | Deutsche Bank AG | |
| 10.03.26 | UBS Underweight | Barclays Capital | |
| 10.03.26 | Givaudan Overweight | Barclays Capital | |
| 09.03.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 09.03.26 | Roche Overweight | Barclays Capital |